<DOC>
	<DOCNO>NCT00966355</DOCNO>
	<brief_summary>In patient suspected variceal bleeding , pharmacologic therapy vasoactive drug terlipressin , somatostatin , octreotide recommend soon possible , even endoscopy . However , still unclear whether efficacy drug . This study perform compare efficacy terlipressin , somatostatin , octreotide patient variceal bleed control variceal bleed combination endoscopic therapy .</brief_summary>
	<brief_title>Comparison Terlipressin , Somatostatin , Octreotide Control Variceal Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<mesh_term>Octreotide</mesh_term>
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>liver cirrhosis age 16 75 year Patients upper GI bleeding symptom ( hematemesis melena ) within 24 hour enrollment Patients whose systolic blood pressure &lt; 100 mmHg pulse rate &gt; 100/min enrollment Patients perform endoscopic pharmacologic therapy varix Signed informed consent Pregnancy Positive antiHIV Ab A history severe sideeffects contraindication study drug Severe cardiovascular disease : acute myocardial infarction , AV block , congestive heart failure , ischemic heart disease , hypertension ( systolic blood pressure &gt; 170 mmHg diastolic pressure &gt; 100 mmHg ) Chronic renal failure Hepatocellular carcinoma protal vein thrombosis Coexisting malignancy except hepatocellular carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Cirrhosis , Esophagus Disorders , Varicose Veins</keyword>
</DOC>